Kristen Stewart

Stock Analyst at CL King

(0.04)
# 2129
Out of 5,243 analysts
37
Total ratings
53.33%
Success rate
6.43%
Average return
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
Haemonetics
Initiates Coverage On: Buy
116
76 52.63% 1 Sep 13, 2024
Merit Medical System...
Initiates Coverage On: Buy
88
101.25 -13.09% 1 Apr 11, 2024
Shockwave Medical
Downgrades: Neutral
n/a
n/a n/a 1 Apr 8, 2024
Integer Holdings
Initiates Coverage On: Buy
n/a
n/a n/a 1 Mar 14, 2024
Axonics
Downgrades: Neutral
n/a
n/a n/a 2 Jan 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
110
163.28 -32.63% 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
22.43 122.92% 1 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Oct 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Aug 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
106
85.39 24.14% 1 Jun 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
64
96.9 -33.95% 1 Jun 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
31
15.71 97.33% 4 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
140
67.93 106.09% 1 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
45
n/a n/a 1 Jul 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
300
234.58 27.89% 2 Jul 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
173 182
145 25.52% 2 Apr 29, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
n/a
n/a n/a 1 Apr 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
116
n/a n/a 1 Mar 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
79 82
70.86 15.26% 5 Jan 31, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
108
105.19 2.67% 2 Jan 3, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
251 255
178.44 42.91% 2 May 4, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Aug 4, 2017